Back

Improved metabolic syndrome-related right and left ventricular dysfunction by the dual ETA-ETB receptor antagonist macitentan.

1 May 2017 (08:30 - 18:00)
Organised by:
Congress Presentation Part of: Poster session 3 - Basic science - Animal experimentation Pulmonary hypertension HFA Premium Access Heart Failure 2017 - 4th World Congress on Acute Heart Failure

About the speaker

Photo
Mrs Marianne Lachaux

INSERM U1096, Rouen (France)

10 More presentations in this session

Presentation thumbnail
Mr M. Amin (Leuven, BE)
Abstract
Presentation thumbnail
Doctor E. Dubois-Deruy (Lille, FR)
Abstract Slides
Presentation thumbnail
Doctor A. Salgado Somoza (Luxembourg, LU)
Abstract
Presentation thumbnail
Mr X. Zhang (Kelvin Grove, AU)
Abstract
Presentation thumbnail
Miss F. Dei Zotti (Brussels, BE)
Abstract

Access the full session

Session thumbnail
Poster session 3 - Basic science - Animal experimentation

The Event

Event poster

Heart Failure 2017 - 4th World Congress on Acute Heart Failure

1 May 2017 08:30 CET
You may be interested in
thumbnail
Congress Presentation
Metabolic syndrome contributes to the pulmonary arterial dysfunction in pulmonary hypertension in heart failure with preserved ejection fraction
31 August 2020
thumbnail
ESC TV Today
Episode 14: Managing hypertension in the elderly - The digital twin in cardiology
24 April 2025
thumbnail
Congress Presentation
Relationship between the right ventricular function and MECKI score in patients with advanced heart failure
25 August 2023
thumbnail
Congress Presentation
Selective endothelin type A receptor blockade attenuates high-output heart failure induced by aorto-caval fistula and renal impairment induced by 5/6 nephrectomy in rats.
22 May 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources